deltatrials
Unknown PHASE1 INTERVENTIONAL 2-arm NCT00895076

Study to Compare the Pharmacokinetics of a Dexamethasone Iontophoretic Patch to a Dexamethasone Injection

A Randomized, Open-Label, Single Dose, Two-Way Crossover Study to Evaluate the Pharmacokinetics and Safety of a Dexamethasone Iontophoretic Transdermal Patch Compared to Dexamethasone Injection in Healthy Adult Volunteers

Sponsor: Cetero Research, San Antonio

Interventions dexamethasone
Updated 5 times since 2017 Last updated: May 6, 2009 Started: May 31, 2009 Primary completion: May 31, 2009 Completion: May 31, 2009
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00895076, this PHASE1 trial focuses on Lateral Epicondylitis (Tennis Elbow) and remains ongoing. Sponsored by Cetero Research, San Antonio, it has been updated 5 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotUnknown Status~Feb 2017 – ~Jan 2021 · 47 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Unknown PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE1

    Status: Unknown StatusUnknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE1

  4. Feb 2017 — Jan 2021 [monthly]

    Unknown Status PHASE1

  5. Jan 2017 — Feb 2017 [monthly]

    Unknown Status PHASE1

    First recorded

May 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Cetero Research, San Antonio
  • Travanti Pharma Inc.
Data source: Travanti Pharma Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations